SCRI FCS North- Ocala — Ocala, Florida

SCRI FCS North- Ocala is a clinical research site located in Ocala, Florida, United States 34474.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI FCS North- Ocala has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Sponsors: Daiichi Sankyo.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ocala

Browse all research sites in Florida · View every site in Ocala

• HCA Florida Ocala Hospital
• West Marion Community Hospital
• Advent Health Ocala/MediQuest Research Group LLC (formerly FL Hospital /Munroe)
• Florida Hospital Ocala
• Munroe Regional Hospital
• Renstar Medical Research
• Ocala Oncology Center
• Research Site
• Pfizer Investigational Site
• GSK Investigational Site
• Ocala Cardiovascular Research
• Novo Nordisk Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI FCS North- Ocala?

SCRI FCS North- Ocala has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI FCS North- Ocala conducted?

SCRI FCS North- Ocala has 1 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Is SCRI FCS North- Ocala accredited by Crixeo Clinical Trials?

SCRI FCS North- Ocala has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI FCS North- Ocala?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.